En Es

Industry News

Utilization of X-Ray Mammography Systems Expected to Increase

By Medimaging International staff writers
10 Oct 2018

Image: The Mammomat Revelation mammography system (Photo courtesy of Siemens Healthineers).Over the last 20 years, hospitals and imaging centers in the developed economies have adopted X-ray mammography systems for the screening and diagnosis of breast cancer. This has resulted in a significant reduction in mortality and encouraged emerging countries to make investments in population-base, organized screening. These significant investments in mammography technology have paved the way for radiation safety, patient comfort and 3D imaging that enables precise tumor detection.

These are the latest findings of Frost & Sullivan, (Santa Clara, CA, USA), a global management consulting company.

Traditionally, highly populated countries have been slow to adopt non-conventional business models, although government initiatives for promoting early tumor detection are anticipated to drive the use of X-ray mammography imaging solutions in these countries. China and Eastern European nations such as Hungary and Poland are likely to be growth hubs for mammography solutions with the governments in these countries rolling out organized, population-based screening. India and other countries in Eastern Europe, such as Romania, are still in the development phase. Vendors in these markets are strategically employing leasing, managed equipment services, and various rental and pay-per-use models to drive procedural volumes. Moreover, new business models that focus on workflow efficiency will be the most feasible on account of the high budget deficits in these markets. At the same time, the evolution of payment models toward outcome-based reimbursement underlines the need for precision diagnosis.

According to Frost & Sullivan, vendors looking to expand their footprint and monetize growth opportunities in the X-ray mammography imaging solutions market need to:
• Offer value-adds through additional software services and improve the value proposition for clinical and financial stakeholders;
• Realign care models to focus on painless patient comfort systems that standardize compression pressure with minimum radiation dose;
• Deliver a fully integrated solution that provides access to medical imaging data as telemammography consultation gains currency;
• Introduce technologies focusing on microcalcifications and breast density assessment; and
• Collaborate with radiographers, medical physicists, and radiologists.
Technology developments in dose reduction, optimization, specificity, and sensitivity for early tumor detection will ensure that mammography remains the preferred imaging tool for breast cancer detection.

"Although analog and computed radiography (CR) mammography will continue to generate revenues from developing economies over the next three to five years, their increasing obsolescence will present considerable opportunities for 2D digital radiography (DR) systems," said Poornima Srinivasan, an industry analyst at Frost & Sullivan. "Studies show that digital breast tomosynthesis (DBT) is a game-changing technology for screening programs due to its ability to detect tumors in women with dense breast tissue. Similarly, 2D DR mammography with 3D DBT enhancement and synthesized 2D imaging also offer high price-performance value."

"To further improve product uptake, vendors are positioning 3D with multi-modality views, setting up workstations with 2D and 3D comparisons, and creating advanced detectors and algorithms to detect cancer at an early stage," added Srinivasan. "Significantly, they are also launching technologies such as contrast-enhanced spectral mammography, which provides low-energy 2D mammographic imaging on par with magnetic resonance imaging (MRI)."

Related Links:
Frost & Sullivan

E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

24 Jun 2019
ACR Releases Second Research Road Map on Medical Imaging AI
The Journal of the American College of Radiology (JACR) has published a report detailing real-world artificial intelligence (AI) challenges and summarizing the priorities for translational research in AI for medical imaging to help accelerate the safe and effective use of AI in clinical practice.
Read More
24 Jun 2019
New AI Tool Helps Detect Brain Aneurysms On CT Angiography Exams
Researchers from Stanford University have developed an artificial intelligence (AI) tool that can help radiologists improve their diagnoses of brain aneurysms by highlighting the areas of a brain scan that are likely to contain an aneurysm.
Read More
24 Jun 2019
Fluoroscopy Equipment Market to Reach USD 7 Billion by 2024
The global fluoroscopy equipment market is projected to grow at a CAGR of 4.4% from USD 5.7 billion in 2019 to USD 7.1 billion by 2024, driven by the advantages of flat panel detectors (FPDs) over image intensifiers, use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, growing prevalence of chronic diseases, and awareness programs, conferences, and funding activities.
Read More
22 Jun 2019
Deep Learning with SPECT MPI Can Help Diagnose Coronary Heart Disease
Researchers from the Cedars-Sinai Medical Center have demonstrated for the first time that deep learning analysis of upright and supine single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) can be used to improve the diagnosis of obstructive coronary artery disease.
Read More
22 Jun 2019
Intelerad to Invest USD 75 Million in New AI Medical Imaging Offerings
Intelerad Medical Systems, a medical imaging software provider that specializes in diagnostic viewing, reporting and collaboration solutions, has announced a USD 75 million R&D investment towards extending its solutions portfolio.
Read More
22 Jun 2019
Global Medical Imaging Equipment Market to Surpass USD 44 Billion by 2025
The global medical imaging equipment market was valued at USD 30.81 billion in 2017 and is expected to grow at a CAGR of 4.6% during the forecast period (2018-2025) to reach USD 44.07 billion by 2025, driven by the increasing incidence of chronic diseases such as liver, cancer, and cardiovascular diseases.
Read More
22 Jun 2019
Increased Monitoring Driving Growth of Global Fetal/Neonatal Equipment Market
The global fetal and neonatal equipment market is projected to grow at a CAGR of 7.4% to reach USD 9.06 billion by 2025, driven mainly by a rise in patient monitoring, especially fetal and neonatal care equipment witnessing increased adoption in basic to advanced equipment across the globe.
Read More
22 Jun 2019
New Augmented Reality Surgical Platform Receives FDA Approval
A new augmented reality (AR) technology platform for surgical applications has received 510(k) clearance for clinical use in the operating room by the US Food and Drug Administration (FDA).
Read More
22 Jun 2019
Demand for Coagulation Testing Driving Global Blood Coagulation Analyzer Market
The global blood coagulation analyzer market is projected to grow at a substantial CAGR of 5.9% over the period 2018 to 2023, driven by its increasing scope, product types, and applications.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions